Global Asthma Immunotherapies Market Growth (Status and Outlook) 2025-2031
According to this study, the global Asthma Immunotherapies market size will reach US$ million by 2031.
Asthma is a condition in which your airways narrow and swell and produce extra mucus.
United States market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Asthma Immunotherapies players cover Anergis, HAL Allergy Group, Merck, ALK-Abello, Stallergenes Greer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Asthma Immunotherapies Industry Forecast” looks at past sales and reviews total world Asthma Immunotherapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Immunotherapies sales for 2025 through 2031. With Asthma Immunotherapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Immunotherapies industry.
This Insight Report provides a comprehensive analysis of the global Asthma Immunotherapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Asthma Immunotherapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Immunotherapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Immunotherapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Immunotherapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Immunotherapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
Asthma is a condition in which your airways narrow and swell and produce extra mucus.
United States market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Asthma Immunotherapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Asthma Immunotherapies players cover Anergis, HAL Allergy Group, Merck, ALK-Abello, Stallergenes Greer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Asthma Immunotherapies Industry Forecast” looks at past sales and reviews total world Asthma Immunotherapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Immunotherapies sales for 2025 through 2031. With Asthma Immunotherapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Immunotherapies industry.
This Insight Report provides a comprehensive analysis of the global Asthma Immunotherapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Asthma Immunotherapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Immunotherapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Immunotherapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Immunotherapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Immunotherapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Anergis
- HAL Allergy Group
- Merck
- ALK-Abello
- Stallergenes Greer
- Laboratorios LETI
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Immunotherapies Market Size (2020-2031)
2.1.2 Asthma Immunotherapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Asthma Immunotherapies by Country/Region (2020, 2024 & 2031)
2.2 Asthma Immunotherapies Segment by Type
2.2.1 Subcutaneous Immunotherapy
2.2.2 Sublingual Immunotherapy
2.3 Asthma Immunotherapies Market Size by Type
2.3.1 Asthma Immunotherapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
2.4 Asthma Immunotherapies Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Asthma Immunotherapies Market Size by Application
2.5.1 Asthma Immunotherapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
3 ASTHMA IMMUNOTHERAPIES MARKET SIZE BY PLAYER
3.1 Asthma Immunotherapies Market Size Market Share by Player
3.1.1 Global Asthma Immunotherapies Revenue by Player (2020-2025)
3.1.2 Global Asthma Immunotherapies Revenue Market Share by Player (2020-2025)
3.2 Global Asthma Immunotherapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ASTHMA IMMUNOTHERAPIES BY REGION
4.1 Asthma Immunotherapies Market Size by Region (2020-2025)
4.2 Global Asthma Immunotherapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Immunotherapies Market Size Growth (2020-2025)
4.4 APAC Asthma Immunotherapies Market Size Growth (2020-2025)
4.5 Europe Asthma Immunotherapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Asthma Immunotherapies Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Asthma Immunotherapies Market Size by Country (2020-2025)
5.2 Americas Asthma Immunotherapies Market Size by Type (2020-2025)
5.3 Americas Asthma Immunotherapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Immunotherapies Market Size by Region (2020-2025)
6.2 APAC Asthma Immunotherapies Market Size by Type (2020-2025)
6.3 APAC Asthma Immunotherapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Asthma Immunotherapies Market Size by Country (2020-2025)
7.2 Europe Asthma Immunotherapies Market Size by Type (2020-2025)
7.3 Europe Asthma Immunotherapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Immunotherapies by Region (2020-2025)
8.2 Middle East & Africa Asthma Immunotherapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Asthma Immunotherapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ASTHMA IMMUNOTHERAPIES MARKET FORECAST
10.1 Global Asthma Immunotherapies Forecast by Region (2026-2031)
10.1.1 Global Asthma Immunotherapies Forecast by Region (2026-2031)
10.1.2 Americas Asthma Immunotherapies Forecast
10.1.3 APAC Asthma Immunotherapies Forecast
10.1.4 Europe Asthma Immunotherapies Forecast
10.1.5 Middle East & Africa Asthma Immunotherapies Forecast
10.2 Americas Asthma Immunotherapies Forecast by Country (2026-2031)
10.2.1 United States Market Asthma Immunotherapies Forecast
10.2.2 Canada Market Asthma Immunotherapies Forecast
10.2.3 Mexico Market Asthma Immunotherapies Forecast
10.2.4 Brazil Market Asthma Immunotherapies Forecast
10.3 APAC Asthma Immunotherapies Forecast by Region (2026-2031)
10.3.1 China Asthma Immunotherapies Market Forecast
10.3.2 Japan Market Asthma Immunotherapies Forecast
10.3.3 Korea Market Asthma Immunotherapies Forecast
10.3.4 Southeast Asia Market Asthma Immunotherapies Forecast
10.3.5 India Market Asthma Immunotherapies Forecast
10.3.6 Australia Market Asthma Immunotherapies Forecast
10.4 Europe Asthma Immunotherapies Forecast by Country (2026-2031)
10.4.1 Germany Market Asthma Immunotherapies Forecast
10.4.2 France Market Asthma Immunotherapies Forecast
10.4.3 UK Market Asthma Immunotherapies Forecast
10.4.4 Italy Market Asthma Immunotherapies Forecast
10.4.5 Russia Market Asthma Immunotherapies Forecast
10.5 Middle East & Africa Asthma Immunotherapies Forecast by Region (2026-2031)
10.5.1 Egypt Market Asthma Immunotherapies Forecast
10.5.2 South Africa Market Asthma Immunotherapies Forecast
10.5.3 Israel Market Asthma Immunotherapies Forecast
10.5.4 Turkey Market Asthma Immunotherapies Forecast
10.6 Global Asthma Immunotherapies Forecast by Type (2026-2031)
10.7 Global Asthma Immunotherapies Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Asthma Immunotherapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Anergis
11.1.1 Anergis Company Information
11.1.2 Anergis Asthma Immunotherapies Product Offered
11.1.3 Anergis Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Anergis Main Business Overview
11.1.5 Anergis Latest Developments
11.2 HAL Allergy Group
11.2.1 HAL Allergy Group Company Information
11.2.2 HAL Allergy Group Asthma Immunotherapies Product Offered
11.2.3 HAL Allergy Group Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 HAL Allergy Group Main Business Overview
11.2.5 HAL Allergy Group Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Asthma Immunotherapies Product Offered
11.3.3 Merck Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 ALK-Abello
11.4.1 ALK-Abello Company Information
11.4.2 ALK-Abello Asthma Immunotherapies Product Offered
11.4.3 ALK-Abello Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ALK-Abello Main Business Overview
11.4.5 ALK-Abello Latest Developments
11.5 Stallergenes Greer
11.5.1 Stallergenes Greer Company Information
11.5.2 Stallergenes Greer Asthma Immunotherapies Product Offered
11.5.3 Stallergenes Greer Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Stallergenes Greer Main Business Overview
11.5.5 Stallergenes Greer Latest Developments
11.6 Laboratorios LETI
11.6.1 Laboratorios LETI Company Information
11.6.2 Laboratorios LETI Asthma Immunotherapies Product Offered
11.6.3 Laboratorios LETI Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Laboratorios LETI Main Business Overview
11.6.5 Laboratorios LETI Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Immunotherapies Market Size (2020-2031)
2.1.2 Asthma Immunotherapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Asthma Immunotherapies by Country/Region (2020, 2024 & 2031)
2.2 Asthma Immunotherapies Segment by Type
2.2.1 Subcutaneous Immunotherapy
2.2.2 Sublingual Immunotherapy
2.3 Asthma Immunotherapies Market Size by Type
2.3.1 Asthma Immunotherapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
2.4 Asthma Immunotherapies Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Asthma Immunotherapies Market Size by Application
2.5.1 Asthma Immunotherapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
3 ASTHMA IMMUNOTHERAPIES MARKET SIZE BY PLAYER
3.1 Asthma Immunotherapies Market Size Market Share by Player
3.1.1 Global Asthma Immunotherapies Revenue by Player (2020-2025)
3.1.2 Global Asthma Immunotherapies Revenue Market Share by Player (2020-2025)
3.2 Global Asthma Immunotherapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ASTHMA IMMUNOTHERAPIES BY REGION
4.1 Asthma Immunotherapies Market Size by Region (2020-2025)
4.2 Global Asthma Immunotherapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Immunotherapies Market Size Growth (2020-2025)
4.4 APAC Asthma Immunotherapies Market Size Growth (2020-2025)
4.5 Europe Asthma Immunotherapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Asthma Immunotherapies Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Asthma Immunotherapies Market Size by Country (2020-2025)
5.2 Americas Asthma Immunotherapies Market Size by Type (2020-2025)
5.3 Americas Asthma Immunotherapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Immunotherapies Market Size by Region (2020-2025)
6.2 APAC Asthma Immunotherapies Market Size by Type (2020-2025)
6.3 APAC Asthma Immunotherapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Asthma Immunotherapies Market Size by Country (2020-2025)
7.2 Europe Asthma Immunotherapies Market Size by Type (2020-2025)
7.3 Europe Asthma Immunotherapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Immunotherapies by Region (2020-2025)
8.2 Middle East & Africa Asthma Immunotherapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Asthma Immunotherapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ASTHMA IMMUNOTHERAPIES MARKET FORECAST
10.1 Global Asthma Immunotherapies Forecast by Region (2026-2031)
10.1.1 Global Asthma Immunotherapies Forecast by Region (2026-2031)
10.1.2 Americas Asthma Immunotherapies Forecast
10.1.3 APAC Asthma Immunotherapies Forecast
10.1.4 Europe Asthma Immunotherapies Forecast
10.1.5 Middle East & Africa Asthma Immunotherapies Forecast
10.2 Americas Asthma Immunotherapies Forecast by Country (2026-2031)
10.2.1 United States Market Asthma Immunotherapies Forecast
10.2.2 Canada Market Asthma Immunotherapies Forecast
10.2.3 Mexico Market Asthma Immunotherapies Forecast
10.2.4 Brazil Market Asthma Immunotherapies Forecast
10.3 APAC Asthma Immunotherapies Forecast by Region (2026-2031)
10.3.1 China Asthma Immunotherapies Market Forecast
10.3.2 Japan Market Asthma Immunotherapies Forecast
10.3.3 Korea Market Asthma Immunotherapies Forecast
10.3.4 Southeast Asia Market Asthma Immunotherapies Forecast
10.3.5 India Market Asthma Immunotherapies Forecast
10.3.6 Australia Market Asthma Immunotherapies Forecast
10.4 Europe Asthma Immunotherapies Forecast by Country (2026-2031)
10.4.1 Germany Market Asthma Immunotherapies Forecast
10.4.2 France Market Asthma Immunotherapies Forecast
10.4.3 UK Market Asthma Immunotherapies Forecast
10.4.4 Italy Market Asthma Immunotherapies Forecast
10.4.5 Russia Market Asthma Immunotherapies Forecast
10.5 Middle East & Africa Asthma Immunotherapies Forecast by Region (2026-2031)
10.5.1 Egypt Market Asthma Immunotherapies Forecast
10.5.2 South Africa Market Asthma Immunotherapies Forecast
10.5.3 Israel Market Asthma Immunotherapies Forecast
10.5.4 Turkey Market Asthma Immunotherapies Forecast
10.6 Global Asthma Immunotherapies Forecast by Type (2026-2031)
10.7 Global Asthma Immunotherapies Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Asthma Immunotherapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Anergis
11.1.1 Anergis Company Information
11.1.2 Anergis Asthma Immunotherapies Product Offered
11.1.3 Anergis Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Anergis Main Business Overview
11.1.5 Anergis Latest Developments
11.2 HAL Allergy Group
11.2.1 HAL Allergy Group Company Information
11.2.2 HAL Allergy Group Asthma Immunotherapies Product Offered
11.2.3 HAL Allergy Group Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 HAL Allergy Group Main Business Overview
11.2.5 HAL Allergy Group Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Asthma Immunotherapies Product Offered
11.3.3 Merck Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 ALK-Abello
11.4.1 ALK-Abello Company Information
11.4.2 ALK-Abello Asthma Immunotherapies Product Offered
11.4.3 ALK-Abello Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ALK-Abello Main Business Overview
11.4.5 ALK-Abello Latest Developments
11.5 Stallergenes Greer
11.5.1 Stallergenes Greer Company Information
11.5.2 Stallergenes Greer Asthma Immunotherapies Product Offered
11.5.3 Stallergenes Greer Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Stallergenes Greer Main Business Overview
11.5.5 Stallergenes Greer Latest Developments
11.6 Laboratorios LETI
11.6.1 Laboratorios LETI Company Information
11.6.2 Laboratorios LETI Asthma Immunotherapies Product Offered
11.6.3 Laboratorios LETI Asthma Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Laboratorios LETI Main Business Overview
11.6.5 Laboratorios LETI Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Asthma Immunotherapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Asthma Immunotherapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous Immunotherapy
Table 4. Major Players of Sublingual Immunotherapy
Table 5. Asthma Immunotherapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Table 8. Asthma Immunotherapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Table 11. Global Asthma Immunotherapies Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Asthma Immunotherapies Revenue Market Share by Player (2020-2025)
Table 13. Asthma Immunotherapies Key Players Head office and Products Offered
Table 14. Asthma Immunotherapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Table 19. Global Asthma Immunotherapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Asthma Immunotherapies Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Asthma Immunotherapies Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Asthma Immunotherapies Market Size Market Share by Country (2020-2025)
Table 23. Americas Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Table 25. Americas Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Table 27. APAC Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Table 29. APAC Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Asthma Immunotherapies Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Asthma Immunotherapies Market Size Market Share by Country (2020-2025)
Table 33. Europe Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Asthma Immunotherapies
Table 39. Key Market Challenges & Risks of Asthma Immunotherapies
Table 40. Key Industry Trends of Asthma Immunotherapies
Table 41. Global Asthma Immunotherapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Asthma Immunotherapies Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Asthma Immunotherapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Asthma Immunotherapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Anergis Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 46. Anergis Asthma Immunotherapies Product Offered
Table 47. Anergis Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Anergis Main Business
Table 49. Anergis Latest Developments
Table 50. HAL Allergy Group Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 51. HAL Allergy Group Asthma Immunotherapies Product Offered
Table 52. HAL Allergy Group Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. HAL Allergy Group Main Business
Table 54. HAL Allergy Group Latest Developments
Table 55. Merck Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 56. Merck Asthma Immunotherapies Product Offered
Table 57. Merck Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Merck Main Business
Table 59. Merck Latest Developments
Table 60. ALK-Abello Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 61. ALK-Abello Asthma Immunotherapies Product Offered
Table 62. ALK-Abello Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. ALK-Abello Main Business
Table 64. ALK-Abello Latest Developments
Table 65. Stallergenes Greer Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 66. Stallergenes Greer Asthma Immunotherapies Product Offered
Table 67. Stallergenes Greer Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Stallergenes Greer Main Business
Table 69. Stallergenes Greer Latest Developments
Table 70. Laboratorios LETI Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 71. Laboratorios LETI Asthma Immunotherapies Product Offered
Table 72. Laboratorios LETI Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Laboratorios LETI Main Business
Table 74. Laboratorios LETI Latest Developments
Table 1. Asthma Immunotherapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Asthma Immunotherapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Subcutaneous Immunotherapy
Table 4. Major Players of Sublingual Immunotherapy
Table 5. Asthma Immunotherapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Table 8. Asthma Immunotherapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Table 11. Global Asthma Immunotherapies Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Asthma Immunotherapies Revenue Market Share by Player (2020-2025)
Table 13. Asthma Immunotherapies Key Players Head office and Products Offered
Table 14. Asthma Immunotherapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Table 19. Global Asthma Immunotherapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Asthma Immunotherapies Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Asthma Immunotherapies Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Asthma Immunotherapies Market Size Market Share by Country (2020-2025)
Table 23. Americas Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Table 25. Americas Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Table 27. APAC Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Table 29. APAC Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Asthma Immunotherapies Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Asthma Immunotherapies Market Size Market Share by Country (2020-2025)
Table 33. Europe Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Asthma Immunotherapies Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Asthma Immunotherapies Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Asthma Immunotherapies Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Asthma Immunotherapies
Table 39. Key Market Challenges & Risks of Asthma Immunotherapies
Table 40. Key Industry Trends of Asthma Immunotherapies
Table 41. Global Asthma Immunotherapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Asthma Immunotherapies Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Asthma Immunotherapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Asthma Immunotherapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Anergis Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 46. Anergis Asthma Immunotherapies Product Offered
Table 47. Anergis Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Anergis Main Business
Table 49. Anergis Latest Developments
Table 50. HAL Allergy Group Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 51. HAL Allergy Group Asthma Immunotherapies Product Offered
Table 52. HAL Allergy Group Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. HAL Allergy Group Main Business
Table 54. HAL Allergy Group Latest Developments
Table 55. Merck Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 56. Merck Asthma Immunotherapies Product Offered
Table 57. Merck Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Merck Main Business
Table 59. Merck Latest Developments
Table 60. ALK-Abello Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 61. ALK-Abello Asthma Immunotherapies Product Offered
Table 62. ALK-Abello Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. ALK-Abello Main Business
Table 64. ALK-Abello Latest Developments
Table 65. Stallergenes Greer Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 66. Stallergenes Greer Asthma Immunotherapies Product Offered
Table 67. Stallergenes Greer Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Stallergenes Greer Main Business
Table 69. Stallergenes Greer Latest Developments
Table 70. Laboratorios LETI Details, Company Type, Asthma Immunotherapies Area Served and Its Competitors
Table 71. Laboratorios LETI Asthma Immunotherapies Product Offered
Table 72. Laboratorios LETI Asthma Immunotherapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Laboratorios LETI Main Business
Table 74. Laboratorios LETI Latest Developments
LIST OF FIGURES
Figure 1. Asthma Immunotherapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Asthma Immunotherapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Asthma Immunotherapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Asthma Immunotherapies Sales Market Share by Country/Region (2024)
Figure 8. Asthma Immunotherapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Asthma Immunotherapies Market Size Market Share by Type in 2024
Figure 10. Asthma Immunotherapies in Hospital Pharmacies
Figure 11. Global Asthma Immunotherapies Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Asthma Immunotherapies in Online Pharmacies
Figure 13. Global Asthma Immunotherapies Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 14. Asthma Immunotherapies in Retail Pharmacies
Figure 15. Global Asthma Immunotherapies Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Asthma Immunotherapies Market Size Market Share by Application in 2024
Figure 17. Global Asthma Immunotherapies Revenue Market Share by Player in 2024
Figure 18. Global Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Figure 19. Americas Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 20. APAC Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 21. Europe Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 23. Americas Asthma Immunotherapies Value Market Share by Country in 2024
Figure 24. United States Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Asthma Immunotherapies Market Size Market Share by Region in 2024
Figure 29. APAC Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 30. APAC Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 31. China Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 35. India Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Asthma Immunotherapies Market Size Market Share by Country in 2024
Figure 38. Europe Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 39. Europe Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 40. Germany Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 41. France Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 54. APAC Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 55. Europe Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 57. United States Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 58. Canada Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 59. Mexico Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 60. Brazil Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 61. China Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 62. Japan Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 63. Korea Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 65. India Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 66. Australia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 67. Germany Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 68. France Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 69. UK Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 70. Italy Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 71. Russia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 72. Egypt Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 73. South Africa Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 74. Israel Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 75. Turkey Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 76. Global Asthma Immunotherapies Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Asthma Immunotherapies Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 1. Asthma Immunotherapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Asthma Immunotherapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Asthma Immunotherapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Asthma Immunotherapies Sales Market Share by Country/Region (2024)
Figure 8. Asthma Immunotherapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Asthma Immunotherapies Market Size Market Share by Type in 2024
Figure 10. Asthma Immunotherapies in Hospital Pharmacies
Figure 11. Global Asthma Immunotherapies Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Asthma Immunotherapies in Online Pharmacies
Figure 13. Global Asthma Immunotherapies Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 14. Asthma Immunotherapies in Retail Pharmacies
Figure 15. Global Asthma Immunotherapies Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Asthma Immunotherapies Market Size Market Share by Application in 2024
Figure 17. Global Asthma Immunotherapies Revenue Market Share by Player in 2024
Figure 18. Global Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Figure 19. Americas Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 20. APAC Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 21. Europe Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Asthma Immunotherapies Market Size 2020-2025 ($ millions)
Figure 23. Americas Asthma Immunotherapies Value Market Share by Country in 2024
Figure 24. United States Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Asthma Immunotherapies Market Size Market Share by Region in 2024
Figure 29. APAC Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 30. APAC Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 31. China Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 35. India Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Asthma Immunotherapies Market Size Market Share by Country in 2024
Figure 38. Europe Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 39. Europe Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 40. Germany Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 41. France Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Asthma Immunotherapies Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Asthma Immunotherapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 54. APAC Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 55. Europe Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 57. United States Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 58. Canada Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 59. Mexico Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 60. Brazil Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 61. China Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 62. Japan Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 63. Korea Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 65. India Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 66. Australia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 67. Germany Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 68. France Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 69. UK Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 70. Italy Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 71. Russia Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 72. Egypt Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 73. South Africa Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 74. Israel Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 75. Turkey Asthma Immunotherapies Market Size 2026-2031 ($ millions)
Figure 76. Global Asthma Immunotherapies Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Asthma Immunotherapies Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Asthma Immunotherapies Market Size 2026-2031 ($ millions)
More Publications
Global Immune Repertoire Sequencing Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
85 pages
Global Kidney Cancer Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
103 pages
Global Neuroblastoma Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
75 pages
Global Infection Control in Cancer Therapy Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
127 pages